A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform by Deeken J F, Cormier T, Price D K, Sissung T M, Steinberg S M, Tran K, Liewehr D J, Dahut W L, Miao X, Figg W D in The pharmacogenomics journal (2010).

[PMID: 20038957] PubMed


Discussed In Paper


Variant Annotations

Sign in to see variant annotations.

Rx Annotations

No dosing information annotated.